People In Brief
This article was originally published in The Tan Sheet
Gros leads Sanofi strategic planning
You may also be interested in...
Schiff Nutrition welcomes Steeves-Kiss
The USP’s general chapter on nitrosamine impurities provides guidance on assessing risks and testing levels of the carcinogens in pharmaceuticals.
Novartis hopes a CAR-T with rapid manufacturing will be a winner, while novel bispecific antibodies in lymphoma and myeloma will make appearances, along with next-generation PI3K and BTK inhibitors.